Skip to main content

Table 1 Baseline characteristics of study patients with hemodialysis

From: A nomogram to predict hyperkalemia in patients with hemodialysis: a retrospective cohort study

Variable

HK

(n = 159)

Non-HK

(n = 242)

P-value

Age, year

61.86 ± 12.22

62.53 ± 15.43

0.631

Blood flow (mm/s)

245.53 ± 27.80

238.80 ± 37.49

0.040

Height(cm)

162.86 ± 8.13

162.39 ± 8.02

0.566

Pre-dialysis weight (kg)

61.08 ± 11.52

58.85 ± 12.02

0.065

Hemoglobin(g/L)

114.22 ± 20.31

104.85 ± 21.94

0.000

Serum sodium(mmol/L)

137.43 ± 3.66

138.84 ± 3.49

0.000

Serum calcium(mmol/L)

2.06 ± 0.46

2.14 ± 0.29

0.050

Albumin(g/L)

37.72 ± 5.97

35.26 ± 5.40

0.000

TC(mmol/L)

4.40 ± 1.27

4.31 ± 1.30

0.497

HDL(mmol/L)

0.99 ± 0.34

0.95 ± 0.36

0.318

Hemodialysis duration (month)

30 (11, 55)

10 (5, 31.25)

<0.001

Number of hemodialysis sessions

267 (104, 308)

92 (17, 245.5)

<0.001

Ultrafiltration volume(L)

3000 (2200, 3500)

2300 (1600, 3000)

<0.001

CRP(mg/L)

2.16 (1, 9.2)

5 (2, 20.05)

0.001

BUN (mmol/L)

24.1 (17.2, 29.5)

15.1 (9.18, 23.25)

<0.001

Uric acid(μmol/L)

382 (295, 469)

336.18 (185.75, 436.75)

0.001

eGFR(ml/min)

4.9 (3.9, 6.7)

7.25 (4.80, 12.30)

<0.001

Glucose(mmol/L)

5.87 (4.89, 8.16)

5.37 (4.59, 7.41)

0.031

Serum creatinine(μmol/L)

778 (614, 953)

581 (346, 804)

<0.001

Serum phosphate(mmol/L)

1.78 (1.31, 2.18)

1.37 (0.99, 1.79)

<0.001

TG(mmol/L)

1.32 (0.92, 2.03)

1.39 (0.96, 1.93)

0.985

LDL(mmol/L)

2.02 (1.48, 2.62)

2.03 (1.58, 2.56)

0.962

PTH(pg/ml)

238 (139.4, 445.6)

213.4 (82.33, 384.45)

0.020

Gender

  

0.292

 Male

90 (56.6%)

151 (62.4%)

 

 Female

69 (43.4%)

91 (37.6%)

 

Primary disease

  

0.309

 Primary nephropathy

59 (37.11%)

107 (44.2%)

 

 Glomerulonephritis

33 (20.75%)

51 (21.07%)

 

 IgA nephropathy

20 (12.58%)

45 (18.59%)

 

 Membranous nephropathy

5 (3.14%)

8 (3.31%)

 

 Interstitial nephritis

1 (0.63%)

3 (1.24%)

 

 Secondary nephropathy

79 (49.69%)

98 (40.5%)

 

 Diabetes nephropathy

37 (23.27%)

43 (17.77%)

 

 Hypertensive nephropathy

42 (26.42%)

55 (22.73%)

 

 Hereditary nephropathy

3 (1.9%)

10 (4.1%)

 

 Unknown etiology

18 (11.32%)

27 (11.16%)

 

Professional

  

0.693

 Farmer

126 (79.7%)

189 (78.1%)

 

 Worker

4 (2.5%)

8 (3.3%)

 

 Clerk

8 (5.1%)

7 (2.9%)

 

 Retirees

7 (4.4%)

19 (7.9%)

 

 Student

0 (0.0%)

1 (0.4%)

 

 Self-employed

8 (5.1%)

11 (4.5%)

 

 Unemployed people

5 (3.2%)

7 (2.9%)

 

Education level

  

0.501

 Primary school diploma

32 (20.3%)

63 (26.0%)

 

 Junior high school diploma

26 (16.5%)

43 (17.8%)

 

 High school diploma

8 (5.1%)

15 (6.2%)

 

 College diploma

6 (3.8%)

11 (4.5%)

 

 Illiteracy

86 (54.4%)

110 (45.5%)

 

Hemodialysis vascular access

  

0.007

 Temporary tube

5 (3.1%)

15 (6.2%)

 

 Long term tube

36 (22.6%)

84 (34.7%)

 

 Fistula

118 (74.2%)

143 (59.1%)

 

Dialysis modalities

  

0.300

 HD

26 (16.4%)

51 (21.1%)

 

 HD + HF

133 (83.6%)

191 (78.9%)

 

Furosemide use

  

0.076

 Yes

118 (74.2%)

158 (65.3%)

 

 No

41 (25.8%)

84 (34.7%)

 

ACEI/ARB

  

0.342

 Yes

103 (64.8%)

169 (69.8%)

 

 No

56 (35.2%)

73 (30.2%)

 

Hypertension

  

0.391

 Yes

39 (24.5%)

50 (20.7%)

 

 No

120 (75.5%)

192 (79.3%)

 

Diabetes mellitus

  

0.040

 Yes

86 (54.1%)

157 (64.9%)

 

 No

73 (45.9%)

85 (35.1%)

 
  1. HK hyperkalemia, TG triglyceride, HDL high-density lipoprotein, CRP C-reactive protein, BUN blood urea nitrogen, eGFR estimated Glomerular Filtration Rate, TC total cholesterol, LDL low-density lipoprotein, PTH parathyroid hormone, HD hemodialysis, HF hemofiltration, ACEI angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker
  2. Categorical variables are presented as n (%). Continuous variables with normal distribution are reported as mean ± SD. Continuous variables with abnormal distribution are given as median (IQR)